ArticleInternational journal of general medicine2025
Exploring Ferroptosis-Related Genes in Depression: Insights Into Molecular Mechanisms and Potential Therapies.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the role of ferroptosis-related genes in depression pathogenesis and identify potential therapeutic strategies through integrated bioinformatics and traditional Chinese medicine (TCM) approaches. Methods: We analyzed the GSE38206 dataset comprising peripheral blood mononuclear cell samples from 9 MDD patients and 9 healthy controls. Bioinformatics analyses including differential expression screening, functional enrichment, and protein-protein interaction network construction were performed to identify ferroptosis-associated hub genes. Potential therapeutic agents were screened through connectivity mapping and TCM network pharmacology analysis. Results: Our analysis identified 60 ferroptosis-related differentially expressed genes and revealed 17 core genes that form a central regulatory network in depression. These genes are primarily involved in inflammatory response, iron metabolism, and oxidative stress pathways. We identified five potential small-molecule compounds (VX-702, gossypol, atomoxetine, TWS-119, and ibudilast) that may target these ferroptosis-related pathways. Additionally, network pharmacology analysis revealed several TCM compounds (including ginseng, saffron, and Salvia miltiorrhiza) that demonstrate multi-target regulatory capabilities consistent with TCM treatment principles. Conclusion: This study provides evidence supporting the involvement of ferroptosis-related mechanisms in depression and proposes a integrative treatment strategy combining targeted molecular interventions with TCM approaches. The findings offer new perspectives for developing therapeutic interventions, particularly for treatment-resistant depression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.